SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-15-070231
Filing Date
2015-02-27
Accepted
2015-02-27 17:10:29
Documents
2
Period of Report
2015-02-24
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d883421d8k.htm 8-K 25525
2 EX-10.1 d883421dex101.htm EX-10.1 17340
  Complete submission text file 0001193125-15-070231.txt   44228
Mailing Address 2130 WEST HOLCOMBE BOULEVARD SUITE 850 HOUSTON TX 77030
Business Address 2130 WEST HOLCOMBE BOULEVARD SUITE 850 HOUSTON TX 77030 (832) 384-1100
BELLICUM PHARMACEUTICALS, INC (Filer) CIK: 0001358403 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36783 | Film No.: 15660409
SIC: 2834 Pharmaceutical Preparations